[go: up one dir, main page]

ATE244299T1 - Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis - Google Patents

Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis

Info

Publication number
ATE244299T1
ATE244299T1 AT94904474T AT94904474T ATE244299T1 AT E244299 T1 ATE244299 T1 AT E244299T1 AT 94904474 T AT94904474 T AT 94904474T AT 94904474 T AT94904474 T AT 94904474T AT E244299 T1 ATE244299 T1 AT E244299T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
testing
demyelinating diseases
relates
present
Prior art date
Application number
AT94904474T
Other languages
English (en)
Inventor
Ellis L Kline
Daniel H Zimmerman
Original Assignee
Molecular Rx Inc
Cell Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Rx Inc, Cell Med Inc filed Critical Molecular Rx Inc
Application granted granted Critical
Publication of ATE244299T1 publication Critical patent/ATE244299T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/838—Marrow; spleen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94904474T 1992-12-18 1993-12-17 Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis ATE244299T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99264192A 1992-12-18 1992-12-18
US16617193A 1993-12-16 1993-12-16
PCT/US1993/012296 WO1994014846A1 (en) 1992-12-18 1993-12-17 Assay and treatment for demyelinating diseases such as multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE244299T1 true ATE244299T1 (de) 2003-07-15

Family

ID=26862018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94904474T ATE244299T1 (de) 1992-12-18 1993-12-17 Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis

Country Status (9)

Country Link
US (2) US5645997A (de)
EP (1) EP0674661B1 (de)
AT (1) ATE244299T1 (de)
AU (1) AU689091B2 (de)
DE (1) DE69333076T2 (de)
NZ (1) NZ259636A (de)
PL (1) PL177771B1 (de)
RU (1) RU2137131C1 (de)
WO (1) WO1994014846A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US20070038231A1 (en) 1999-05-28 2007-02-15 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
DK1272211T3 (da) * 2000-04-07 2007-10-01 Signal Coordinating Therapy In Fremgangsmåder og sammensætninger til behandling af neoplasmer
AU7931301A (en) 2000-08-04 2002-02-18 Dmi Biosciences Inc Method of using diketopiperazines and composition containing them
WO2003001212A2 (en) * 2001-06-22 2003-01-03 Burkhard Jansen A method for diagnosing a person having multiple sclerosis
ATE520981T1 (de) * 2002-10-02 2011-09-15 Dmi Biosciences Inc Diagnose und überwachung von krankheiten
CN101947306B (zh) 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
WO2006076371A2 (en) * 2005-01-10 2006-07-20 Baylor College Of Medicine Method of quantitative immunohistochemistry and in situ hybridization
US8658622B2 (en) * 2005-01-14 2014-02-25 Regents Of The University Of California Methods and compositions for preventing and treating a disease related to glycan dysregulation
WO2009146320A1 (en) * 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
JP2013537195A (ja) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション 疾患の治療
ES2795803T3 (es) 2011-10-10 2020-11-24 Ampio Pharmaceuticals Inc Tratamiento de artropatía degenerativa
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
KR20140095479A (ko) 2011-10-28 2014-08-01 앰피오 파마슈티컬스 인코퍼레이티드 비염의 치료
EP2968315B1 (de) 2013-03-15 2020-06-03 Ampio Pharmaceuticals, Inc. Zusammensetzungen für mobilisierung, homing, expansion und differenzierung von stammzellen und verfahren zur verwendung davon
CN106604915A (zh) 2014-08-18 2017-04-26 安皮奥制药股份有限公司 关节病症的治疗
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932601A (en) * 1971-04-07 1976-01-13 Cornell Research Foundation, Inc. Method and composition for the diagnosis of equine infectious anemia virus infection by using agar-gel-immunodiffusion reaction
US3929982A (en) * 1971-11-05 1975-12-30 Cornell Res Foundation Inc Method and composition for the diagnosis of equine infectous anemia virus infection by using agar-gel-immunodiffusion reaction
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
WO1992015884A1 (en) * 1991-03-08 1992-09-17 The Uab Research Foundation Novel protein, method and products for detection of oligodendrocytes
CA2110055C (en) * 1991-05-31 2002-08-20 Arthur A. Vandenbark T cell receptor peptides as therapeutics for immune-related disease

Also Published As

Publication number Publication date
EP0674661A4 (de) 1997-12-10
PL177771B1 (pl) 2000-01-31
EP0674661A1 (de) 1995-10-04
DE69333076T2 (de) 2004-04-15
PL309637A1 (en) 1995-10-30
AU5850994A (en) 1994-07-19
EP0674661B1 (de) 2003-07-02
NZ259636A (en) 1997-10-24
WO1994014846A1 (en) 1994-07-07
AU689091B2 (en) 1998-03-26
US5883227A (en) 1999-03-16
DE69333076D1 (de) 2003-08-07
RU2137131C1 (ru) 1999-09-10
US5645997A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
Savage et al. Antineutrophil cytoplasm antibodies in Kawasaki disease.
ATE255902T1 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten
ES2061730T3 (es) Nuevos anticuerpos.
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
NO941370D0 (no) Rekombitope peptider
FR2637600B1 (fr) Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
Moutsopoulos et al. B lymphocyte antigens in sicca syndrome
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
ATE297983T1 (de) Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1
ATE86633T1 (de) Snrnp-a-antigen und fragmente davon.
Schneiderman et al. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
FI922666A0 (fi) Diagnostiskt foerfarande.
WUEPPER et al. Serologic tests for syphilis and the false-positive reactor
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
Mach et al. D-penicillamine: a modulator of anti-DNA antibodies production
DE69027025D1 (de) Testverfahren für und behandlung von autoimmunkrankheiten
Kaufman et al. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome: demonstration of unique antigen-antibody specificities
Narayan et al. Fractionation, characterization and diagnostic potential of circulating leprosy antigens isolated from sera of lepromatous leprosy patients
Stefaniak Detection of the Haemophilus somnus antibodies in the bulls' reproductive tract fluids using the ELISA. II. Occurrence of specific antibodies in bulls from three Bull Rearing Centers
Salo et al. Quantitative Reiter protein complement-fixation test
FI922667A0 (fi) Diagnostiskt foerfarande.
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0674661

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee